Report Company Directory
- DSS, Inc.’s Subsidiary, Impact BioMedical Inc., Announces Strategic Merger by GlobeNewsWire
- DSS, Inc. Reports Strong Q1 2025 Financial Performance, Setting the Stage for Strategic Growth by GlobeNewsWire
- Sentinel Brokers Company, Inc., a Subsidiary of DSS, Inc., Receives FINRA Approval to Act as Underwriter and Selling Group Member for Corporate Securities Offerings by GlobeNewsWire
- DSS, Inc. Announces Sale of Celios® to Impact BioMedical, Streamlining Portfolio for Strategic Growth by GlobeNewsWire
- DSS, Inc. Issues Letter to Shareholders by GlobeNewsWire
- DSS Inc: 1 director by SmartInsider
- DSS, Inc. Celebrates Impact BioMedical Inc.'s Successful IPO and Proudly Advances Shareholder Value by GlobeNewsWire
- AmericaFirst Funds Trust Announces Changes to Board of Trustees by GlobeNewsWire
- DSS, Inc. Names Jason Grady as Interim Chief Executive Officer by GlobeNewsWire
- Impact Biomedical, Inc. Announces U.S. Patent Allowance of Laetose™ Technology Entitled "Low Glycemic Sugar Composition." by GlobeNewsWire